242 related articles for article (PubMed ID: 31683483)
1. Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial.
Ochiai R; Saitou K; Suzukamo C; Osaki N; Asada T
J Alzheimers Dis; 2019; 72(4):1209-1216. PubMed ID: 31683483
[TBL] [Abstract][Full Text] [Related]
2. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
3. Effect of Chlorogenic Acids on Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial.
Saitou K; Ochiai R; Kozuma K; Sato H; Koikeda T; Osaki N; Katsuragi Y
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30241302
[TBL] [Abstract][Full Text] [Related]
4. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Dichgans M; Markus HS; Salloway S; Verkkoniemi A; Moline M; Wang Q; Posner H; Chabriat HS
Lancet Neurol; 2008 Apr; 7(4):310-8. PubMed ID: 18296124
[TBL] [Abstract][Full Text] [Related]
5. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
[TBL] [Abstract][Full Text] [Related]
6. Construction and evaluation of multidomain attention training to improve alertness attention, sustained attention, and visual-spatial attention in older adults with mild cognitive impairment: A randomized controlled trial.
Yang HL; Chu H; Kao CC; Miao NF; Chang PC; Tseng P; O'Brien AP; Chou KR
Int J Geriatr Psychiatry; 2020 May; 35(5):537-546. PubMed ID: 31994767
[TBL] [Abstract][Full Text] [Related]
7. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
[TBL] [Abstract][Full Text] [Related]
9. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
10. Short-Term Intake of Chlorogenic Acids Improves Psychomotor Speed and Motor Speed in Adults: A Randomized Crossover Trial.
Suzukamo C; Ochiai R; Mitsui Y; Osaki N; Ono T
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326326
[TBL] [Abstract][Full Text] [Related]
11. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
[TBL] [Abstract][Full Text] [Related]
12. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
[TBL] [Abstract][Full Text] [Related]
13. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
Nogueira J; Freitas S; Duro D; Almeida J; Santana I
Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.
Grove RA; Harrington CM; Mahler A; Beresford I; Maruff P; Lowy MT; Nicholls AP; Boardley RL; Berges AC; Nathan PJ; Horrigan JP
Curr Alzheimer Res; 2014 Jan; 11(1):47-58. PubMed ID: 24359500
[TBL] [Abstract][Full Text] [Related]
15. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
Papp E; Pákáski M; Drótos G; Kálmán J
Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
[TBL] [Abstract][Full Text] [Related]
16. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Wagg A; Dale M; Tretter R; Stow B; Compion G
Eur Urol; 2013 Jul; 64(1):74-81. PubMed ID: 23332882
[TBL] [Abstract][Full Text] [Related]
17. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
